Skip to main content
Advanced Technical IVT

minimal change disease

The most common cause of nephrotic syndrome in children, characterized by normal glomerular appearance on light microscopy but podocyte foot process effacement on electron microscopy.

Full Definition

Minimal change disease accounts for 80-85% of nephrotic syndrome cases in children aged 2-8 years. The condition is characterized by selective proteinuria with normal kidney function and absence of hematuria or hypertension. Kidney biopsy shows normal glomeruli on light microscopy and immunofluorescence, but electron microscopy reveals diffuse podocyte foot process effacement. The disease typically responds dramatically to corticosteroid therapy, with 90% of children achieving remission within 4-6 weeks. Frequent relapses may occur, requiring long-term immunosuppressive management in steroid-dependent cases.

Usage

Usage note: Emphasize the excellent prognosis and steroid responsiveness when documenting MCD in pediatric patients.

In Context

  • "Kidney biopsy confirmed minimal change disease as the underlying cause of steroid-sensitive nephrotic syndrome." — Pathology report
  • "Children with minimal change disease typically achieve complete remission with prednisolone therapy within 8 weeks." — Treatment guideline

Also known as

MCD lipoid nephrosis

Don't confuse with

focal segmental glomerulosclerosis membranous nephropathy

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON